Tag Archive for: siRNA

GSK's incoming CEO Luke MielsGSK
Licence deal

GSK licences siRNA COPD drug in US$745m biobucks deal

British GlaxoSmithKline plc (GSK) has entered a US$745m licensing agreement with Empirico Inc for EMP-012, a first-in-class siRNA candidate for COPD. EMP-012 targets the underserved non-type 2 inflammation market segment valued at US$600–700bn.

Read more
Alpha-Synuclein staining of a Lewy body in the substantia nigra in Parkinson's disease.Marvin 101 - wikipedia.org
Licence deal

Novartis invests US$200min lacklustre Parkinson’s target

Swiss pharma major Novartis AG is investing money in the inhibition of the Parkinson’s target alpha-synuclein, which has already failed several times in clinical trials. The Swiss company is licensing the siRNA programme ARO-SNCA from Arrowhead Pharmaceuticals for US$200m.

Read more